Lovastatin Tablet
Product Images NDC 83209-468

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 83209-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Boswell Pharmacy Services Llc D/b/a Bps Wholesale, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin (65abb8c3 847f 4fb3 B8de 21888c01210b 01)

Chemical structure diagram of lovastatin, depicting its molecular framework with labeled functional groups and bonds, consistent with the generic drug lovastatin.*

FDA Label Image

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' comparing the proportion of participants without events over 6 years of follow-up between Lovastatin and placebo groups. The graph shows a higher proportion without events for Lovastatin, with a noted 37% risk reduction (p<0.0001) compared to placebo.*

FDA Label Image

Lovastatin 20mg (30)

Lovastatin USP 20 mg tablet label showing a package containing 30 tablets. The label notes the NDC 83209-468-30 and indicates the product is for institutional use only. It is repackaged by BPS Wholesale, with original manufacture by Lupin Pharmaceuticals, Inc. Storage instructions and batch information are also provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.